Co-Diagnostics (CODX) Announces $5.5 Million Registered Direct Offering of Common Stock

January 31, 2019 8:08 AM EST Send to a Friend
Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login